Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Hühn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomacromolecules|February 4, 2010
Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomesAnna Maria Hofmann, Frederik Wurm, Eva Hühn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2010
Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imagingEva Hühn, Hans-Georg Buchholz, Gamal Shazly, et al.
Molecular Pharmaceutics|December 13, 2017
Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral AdministrationAntje Ziller, Sara S Nogueira, Eva Hühn, et al.
Journal of Medicinal Chemistry|March 8, 2023
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory PathologiesEmmanuel A Meyer, Päivi Äänismaa, Eric A Ertel, et al.
Chemmedchem|March 12, 2025
Discovery of Galactopyranose-1-carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin-3 InhibitorsCornelia Zumbrunn, Luboš Remen, Christoph P Sager, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomacromolecules|February 4, 2010
Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomesAnna Maria Hofmann, Frederik Wurm, Eva Hühn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2010
Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imagingEva Hühn, Hans-Georg Buchholz, Gamal Shazly, et al.
Molecular Pharmaceutics|December 13, 2017
Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral AdministrationAntje Ziller, Sara S Nogueira, Eva Hühn, et al.
Journal of Medicinal Chemistry|March 8, 2023
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory PathologiesEmmanuel A Meyer, Päivi Äänismaa, Eric A Ertel, et al.
Chemmedchem|March 12, 2025
Discovery of Galactopyranose-1-carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin-3 InhibitorsCornelia Zumbrunn, Luboš Remen, Christoph P Sager, et al.
Pageof 1